3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
25
Leukemia
13
Neuroblastoma
12
Myelodysplastic Syndromes
12
Multiple Myeloma
12
Recurrence
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Lymphoma
8
Sarcoma
7
Medulloblastoma
7
Astrocytoma
7
Lymphoma, Non-Hodgkin
6
Wilms Tumor
5
Osteosarcoma
5
Central Nervous System Neoplasms
5
Brain Neoplasms
5
Sarcoma, Ewing
4
Rhabdoid Tumor
4
Retinoblastoma
4
Optic Nerve Glioma
4
Neoplasms
4
Myeloproliferative Disorders
4
Lymphoma, Mantle-Cell
4
Lymphoma, Follicular
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia, Biphenotypic, Acute
4
Hodgkin Disease
4
Hematologic Neoplasms
4
Burkitt Lymphoma
4
Testicular Neoplasms
3
Interventions
Cyclophosphamide
3
Topotecan
2
seclidemstat
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
fludarabine phosphate
1
fludarabine
1
Sirolimus
1
Simvastatin
1
Mesna
1
Granulocyte Colony-Stimulating Factor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Sarcoma, Clear Cell
×
Granulocyte Colony-Stimulating Factor
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled